H.R. 9559 · 119th Congress · Health

IBOGAINE Act

Regulates ibogaine drug research, development, or medical use. AI-read

In committee4k words Introduced Jun 30, 2026 · Latest action Jul 17, 2026

How far it has goneStage 2 of 6
  1. IntroducedJun 30, 2026 Done
  2. CommitteeReferred to 3 committees Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

No lobbying filing on file names H.R. 9559.

Organizations that named H.R. 9559 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

3 actions · newest first
  1. Jul 17, 2026Referred to the Subcommittee on Health.
  2. Jun 30, 2026Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  3. Jun 30, 2026Introduced in House